Search
for
Sort by
Research 691–720 of 1000+
- Tombo em João Pessoa dá força a Memorial da Arquitetura Paraibana
- Dermatologic adverse events in EGFR-TKIs: A real-world analysis.
- 061 Selective inhibition of tyrosine kinase 2 prevents and restores interleukin-12-induced hair follicle immune privilege collapse: a novel approach to alopecia areata therapy?
- A Case of Hair Change and Acneiform Eruption Induced by ZD1839 (Iressa$^{(R)}$)
- c-Kit - The Novel Receptor: Physiological Roles, Downstream Signaling and Implications in Cancer
- 3D organotypic skin models recapitulate autoantibody-driven pemphigus pathomechanisms and targeted therapeutic response
- Drug Repurposing Patent Applications April–June 2021
- A Case of Inflammatory Nonscarring Alopecia Associated With the Tyrosine Kinase Inhibitor Nilotinib
- 014 Tyrosine Kinase 2 Inhibition Ameliorates the Phenotype of Lesional Alopecia Areata Scalp Skin Ex Vivo, and Reverses the Induction of Human Alopecia Areata in a Humanized Mouse Model
- 700 Tyrosine kinase 2 inhibition rescues hair follicles from IL-12–mediated immune privilege collapse and reverses the induction of human alopecia areata in a humanized mouse model
- Tyrosine Kinase Inhibitors against Cancer: Their Safety in 216 Moroccan Patients
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Tyrosine kinase Inhibitors in Dermatology: A Systemic Review
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Dasatinib-Induced Leukotrichia in a Patient With Chronic Myelogenous Leukemia
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- Inhibition of a signaling modality within the gp130 receptor enhances tissue regeneration and mitigates osteoarthritis
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Unusual progression of renal cell carcinoma with carcinomatosis peritoneii and Krukenberg tumour and alopecia with sunitinib therapy in young female
- Unexpected hair growth induced by gefitinib treatment in two patients with EGFR gene mutation-positive adenocarcinoma of the lung
- Nilotinib-induced generalized keratosis pilaris: Report of a rare case
- Gefitinib-induced hair alterations: Figure 1
- Are all adverse effects undesirable? a case of chemotherapy induced adverse effect- an exception!?
- Drug-induced hair pigmentation: Clinical perspectives and updates
- Rapid hair depigmentation in patient treated with pazopanib
- Erosive pustular dermatosis of the scalp induced by gefitinib: case and review of the literature
- The Dark Side of Gefitinib: Reflectance Confocal Microscopy Applied to Hair Hyperpigmentation
- Drug-induced scarring and permanent alopecia
- Ponatinib-induced pityriasis rubra pilaris-like adnexal dysmaturation: A case report